10 Drugs That Could be Johnson & Johnson (JNJ)'s New Blockbusters
11/2/2016 6:04:11 AM
When it comes to steady investments, there may be no rock more solid in the healthcare space than Johnson & Johnson (NYSE:JNJ).
Johnson & Johnson's stability arises from the diversity of its sales and the inelasticity of its products. J&J offers its products throughout the world, and its revenue is split pretty evenly between consumer health products, medical devices, and pharmaceuticals, leading to predictable cash flow and profitability. Furthermore, since consumers can't control when they get sick or what disease or disorder they contract, J&J's products are always in demand.
comments powered by